메뉴 건너뛰기




Volumn 80, Issue 2, 2008, Pages

The Effect of pioglitazone on circulating adiponectin is highly predictable based on its basal level

Author keywords

Adiponectin; Pioglitazone; Thiazolidinedione derivative

Indexed keywords

ADIPONECTIN; GLUCOSE; PIOGLITAZONE;

EID: 41749102878     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2008.01.026     Document Type: Letter
Times cited : (4)

References (6)
  • 1
    • 19244365650 scopus 로고    scopus 로고
    • Thiazolidinediones
    • Yki-Järvinen H. Thiazolidinediones. N. Engl. J. Med. 351 (2004) 1106-1118
    • (2004) N. Engl. J. Med. , vol.351 , pp. 1106-1118
    • Yki-Järvinen, H.1
  • 2
    • 26244453309 scopus 로고    scopus 로고
    • Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitazone clinical trial in macrovascular events): a randomised controlled trial
    • Dormandy J.A., Charbonnel B., Eckland D.J.A., Erdmann E., Massi-Benedetti M., Moules I.K., et al. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitazone clinical trial in macrovascular events): a randomised controlled trial. Lancet 366 (2005) 1279-1289
    • (2005) Lancet , vol.366 , pp. 1279-1289
    • Dormandy, J.A.1    Charbonnel, B.2    Eckland, D.J.A.3    Erdmann, E.4    Massi-Benedetti, M.5    Moules, I.K.6
  • 3
    • 34249869805 scopus 로고    scopus 로고
    • Pioglitazone rapidly increases serum adiponectin levels in men with normal glucose tolerance
    • Ikeda Y., Takata H., Inoue K., Shinahara M., Inada S., Maruyama H., et al. Pioglitazone rapidly increases serum adiponectin levels in men with normal glucose tolerance. Diabetes Care 30 (2007) e48
    • (2007) Diabetes Care , vol.30
    • Ikeda, Y.1    Takata, H.2    Inoue, K.3    Shinahara, M.4    Inada, S.5    Maruyama, H.6
  • 4
    • 33745834319 scopus 로고    scopus 로고
    • Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome
    • Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., and Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Invest. 116 (2006) 1784-1792
    • (2006) J. Clin. Invest. , vol.116 , pp. 1784-1792
    • Kadowaki, T.1    Yamauchi, T.2    Kubota, N.3    Hara, K.4    Ueki, K.5    Tobe, K.6
  • 5
    • 33646852805 scopus 로고    scopus 로고
    • Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways
    • Kubota N., Terauchi Y., Kubota T., Kumagai H., Itoh S., Satoh H., et al. Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways. J. Biol. Chem. 281 (2006) 8748-8755
    • (2006) J. Biol. Chem. , vol.281 , pp. 8748-8755
    • Kubota, N.1    Terauchi, Y.2    Kubota, T.3    Kumagai, H.4    Itoh, S.5    Satoh, H.6
  • 6
    • 0036061598 scopus 로고    scopus 로고
    • Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population
    • Hara K., Boutin P., Mori Y., Tobe K., Dina C., Yasuda K., et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51 (2002) 536-540
    • (2002) Diabetes , vol.51 , pp. 536-540
    • Hara, K.1    Boutin, P.2    Mori, Y.3    Tobe, K.4    Dina, C.5    Yasuda, K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.